KOCH Clinical Research is leading the way in evaluating new technologies for Glucose monitoring, focusing on understanding glycemic patterns in individuals.
Be Part of the Future of Glucose Monitoring!
Diabetes and prediabetes are major global health concerns. By participating in this cgm study Central Illinois, you can help advance research to improve diagnosis and management strategies.
The Continuous Glucose Monitoring System aims to revolutionize glycemic monitoring by providing real-time insights into blood sugar trends. Your involvement could shape the future of glucose monitoring technology!
Risk Factors
- Obesity
- Sedentary lifestyle
- Family history of diabetes
- Poor dietary habits
- Stress
Disclaimer
**Participation in the study, including all procedures and treatments, is provided at no cost. Enrollment does not require health insurance**
Enroll Now!
Interested in participating in a clinical trial?
Continuous Glucose Monitor Clinical Trials in Central Illinois
This CGM clinical trials Central Illinois study aims to assess the safety and effectiveness of the device in identifying glycemic patterns.
But why join this study?
- Help evaluate innovative technology for monitoring glucose levels.
- Contribute to advancements in prediabetes diagnosis and care.
- Receive study-related care at no cost.
- Insurance is not required.
This study aims to gain invaluable insights into prediabetes diagnosis and care, yielding developments and innovation for all those having the susceptibility.
Eligibility Criteria
- Age: 18 years and older
- Gender : Male & Female
- Condition : Glucose
- Total Studies : 01
- Status : Not Recruiting
Advancing Glucose Monitoring Through Innovation
Continuous Glucose Monitor Clinical Trials in Central Illinois are designed to evaluate the safety, reliability, and accuracy of the Continuous Glucose Monitoring System. The study focuses on understanding glycemic patterns in individuals with and without prediabetes, comparing traditional diagnostic methods like HbA1c and Fasting Plasma Glucose with real-time CGM data. By participating in this groundbreaking research, you’ll contribute to advancing diabetes care.
Frequently Asked Questions
What is the purpose of this clinical trial?
This study aims to assess the safety and effectiveness of the FreeStyle Libre 3 Continuous Glucose Monitoring System in identifying glycemic patterns, particularly in individuals with and without prediabetes. It also compares traditional diagnostic methods with CGM data to improve prediabetes diagnosis.
Who is eligible to participate in the study?
Participants must be 18 years or older, able to read and understand English, willing to fast for at least eight hours, provide blood samples, and attend all study visits. Individuals with diabetes, on specific medications, or following restrictive diets are excluded.
Is there any cost to participate in the trial?
No, there is no cost to participate. All study-related care, tests, and procedures are provided free of charge, and no health insurance is required.
How will this trial benefit participants?
Participants will contribute to advancing diabetes research, help refine diagnostic tools for prediabetes, and gain insights into their glycemic health through cutting-edge technology—all at no cost.
